Anhui Fengyuan Pharmaceutical Co., Ltd. (SHE:000153)
China flag China · Delayed Price · Currency is CNY
6.25
-0.16 (-2.50%)
Sep 10, 2026, 3:04 PM CST

SHE:000153 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Net Income
93.4299.42160.83159.29154.43122.98
Depreciation & Amortization
146.24148127.84126.32121.7115.31
Other Amortization
15.9814.9616.114.4413.0210.94
Loss (Gain) From Sale of Assets
0.330.331.61-4.380.250.51
Asset Writedown & Restructuring Costs
27.364.180.010.280.018.57
Loss (Gain) From Sale of Investments
-16.11-4.94-3.941.58-14.82-9.73
Provision & Write-off of Bad Debts
12.5715.767.380.694.511.54
Other Operating Activities
40.6542.9734.6436.9139.3540.39
Change in Accounts Receivable
61.07-52.62-165.39-238.77-89.26-114.07
Change in Inventory
30.0146.05-18.38126.41-44.9-40.4
Change in Accounts Payable
-231.1-188.35-33.254.5261.41138.84
Change in Other Net Operating Assets
6.12-----
Operating Cash Flow
174.83119.3126.24254.75439.99264.62
Operating Cash Flow Growth
43.46%-5.50%-50.45%-42.10%66.27%-9.61%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Capital Expenditures
-126.31-220.61-144.02-152.12-81.76-159.84
Sale of Property, Plant & Equipment
0.40.410.473.15.631.05
Investment in Securities
-60-58.6-117.18--276.9
Other Investing Activities
8.568.569.275.363.740.34
Investing Cash Flow
-177.35-270.24-251.45-143.66-99.39-151.56

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Long-Term Debt Issued
-1,5341,156887.62855.6900.6
Total Debt Issued
1,7101,5341,156887.62855.6900.6
Long-Term Debt Repaid
--1,260-1,033-993.2-834.56-1,002
Lease Payments
13.42---26.15-30.26-33.7
Total Debt Repaid
-1,324-1,260-1,033-993.2-834.56-1,002
Net Debt Issued (Repaid)
385.99274.48123.08-105.5821.04-100.99
Issuance of Common Stock
----82.48-
Repurchase of Common Stock
-0.2-0.2-0.18-0.35--
Common Dividends Paid
-81-81.16-72.17-64.17-57.48-26.28
Other Financing Activities
-12.48-130-0.14.9-308.31-
Financing Cash Flow
292.3163.1250.63-165.2-262.27-127.27

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Foreign Exchange Rate Adjustments
-0.07-0.020.170.170.09-0.34
Net Cash Flow
289.71-87.84-74.43-53.9378.42-14.54

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
48.52-101.31-17.78102.64358.23104.78
Free Cash Flow Growth
----71.35%241.90%2.71%
Free Cash Flow Margin
1.39%-2.63%-0.41%2.40%8.95%2.87%
Free Cash Flow Per Share
0.10-0.22-0.040.220.810.24
Levered Free Cash Flow
17.72184.15-147.11-126.98450.22-145.6
Unlevered Free Cash Flow
29.62206.16-128.13-105.8470.76-121.06
Free Cash Flow After Leases
61.94-101.31-17.7876.49327.9771.08

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash Income Tax Paid
167.2176.72206.74282.07180.28181.46
Change in Working Capital
-145.6-201.38-218.23-80.37121.54-25.9